Introduction
The term 'chaos theory' suggests disorder and unpre-( Figure 1 ). A more familiar example of this principle is the problem of weather forecasting. Very small dictability, which is partially right, but does not represent the other very important aspect of chaotic changes in initial conditions can produce large changes in the weather, even in the short to medium systems-that they are deterministic, with changes occuring only within prescribed borders. Their unpreterm, making forecasting extremely difficult. Lorenz tried to solve this problem during WWII so that the dictability arises because minuscule changes in the starting conditions of a chaotic system can produce weather could be more accurately predicted for airforce sorties.1 Working with a simple computer, he widely different outcomes. A good example of this is a simplified vertical pinball machine, where a ball realized that repeated equations in which several decimal places were rounded up (e.g. 2.978658 is dropped and its path is interrupted by two rows of equally spaced pins, finally landing in one of 16 becomes 2.97866) gave different results, leading to the conclusion that small changes in the initial different pockets. The interaction with the first row of pins greatly amplifies any minor difference conditions can lead to highly diverse outcomes. Lorenz predicted that if we had supercomputers (to between one try and the next, and this is again amplified by the interaction with the next row. In handle all the decimal places) and means of obtaining accurate information, such as satellites, practical terms, it is impossible to predict in which pocket the ball will come to rest, even if the greatest then we would be able to forecast the day-to-day weather much more accurately. The advent of supercare is taken to reproduce the previous result
The weather and the immune systems
It is likely that the non-linear dynamics used to model weather systems are also applicable to biological systems. Biological systems are inherently variable, and need to be so to adapt to changing environments.3 Biological systems are also inherently lazy, in that if a formula works it will be re-iterated again and again rather than expending the energy involved in finding a new solution. This is seen repeatedly in biological systems from gross structural anatomy all the way through to basic developmental genes. In higher organisms, there are two major complex systems that interact with the environment. One is the nervous system, which receives the various senses, and the other is the immunological system, which identifies and repels dangerous microorganisms. Both are exceedingly complex, interactive, and capable of memory. The immune system Figure 1 . Cartoon of apparatus to demonstrate the unprehas many layers of function, from mucosal and dictability of a ball dropped from the same site and height innate immunity through to highly specific humoral and ending up in a specific hole, its route being altered at random by the first and/or second row of pins.
and cell-mediated response recognition. It is 'set' to differentiate between self and non-self early on in life, and even though it produces hundreds of milcomputers and satellites has enabled this prediction lions of T cells, it deletes the majority because they to come true, at least for short-to medium-term recognize self. Although the details of how this is forecasting. Lorenz himself devised a computer and achieved and how the resultant immune system a program to perform some of these calculations, matures and evolves as the body ages are far from which form the basis of what is loosely known as clear, it is amazing that, given the similarity of many chaos theory. It is important to appreciate that a lot micro-organisms to self antigens, it is so effective in of 'chaos' results from simple re-iteration of simple controlling microbiological organisms and yet so equations ( Figure 2 ). Indeed, re-iterating some of tolerant of self antigens. The consequence of this these equations can lead to wonderful complex system when it fails are fortunately much more rare structures, such as the Mandelbrot set which, while than theory would suggest, and are manifested in ever diversifying at higher magnification, always conditions such as rheumatoid arthritis, multiple appears to come back to its original shape, with sclerosis, diabetes, etc. It is therefore likely that the many repetitions of recognizable forms or fractals immune system focuses around strange attractors visible at different levels of magnification ( Figure 2) . along the lines suggested by Lorenz for his weather There is an inherent variability in these forms, many systems. What these attractors are, we do not know, of which are similar to biological structures. It is the but there is increasing evidence that there is a ability of chaos to form repeatable, recognizable focusing of the immune system based on minor structures on different scales, such as fractals, and differences in its own self make-up. Good examples also to return to previous starting points of forms, of this are given by Ira Cohen4 and his theory encompassing what Lorenz called the strange that HLA and immunoglobulin act as a homunculus, attractor, which provides the excitement in applying in which he suggests that the immune system is this approach to biological problems, especially focused on regions of HLA and immunoglobin cancer.
because these are the components that pathogenic The limitation of variability in that it takes place micro-organisms have most often hijacked. Therefore within a certain wedge of possibilities, was first the immune system is tuned to attack invading hosts noted by the French mathematician Poincaré, who bearing such sequences rapidly, and we do not have noted that the expression of a variable mathematical to wait weeks for the relevant immune response to problem was always confined to a certain area or be made. That this focused attack can be effective, box.2 That chaotic variability has an inherent predictand reduce a micro-organism load which is similar ability can be seen in the weather. Although it is enough to self to cause an auto-immune attack, is extremely difficult to predict the weather in 3 to 4 demonstrated by auto-immune phenomena such as weeks, it is likely that in 12 months the weather will skin rashes, arthritis, etc. which accompany most be roughly similar to now, and that the seasons will follow in a recognizable pattern of change.
acute micro-organism infections, albeit transiently.
Cohen claims that these features settle down followpossibility that the chances of some of these approaches working would be greatly increased if ing the fine tuning of immune responses to the HLAlike sequences, focusing on specific epitopes of the major immunological attractors could be 'reset', is clearly attractive. invading agent. This theory is basically a further embellishment of the role of HLA and immunoglobin
The concept of resetting the immune system has been proposed previously by Jerne,7 who proposed in determining self from non-self.
the network theory of the immune system, and suggested that anti-idiotype antibodies maintained a stable immune system and could also be used as system may well eliminate cancers in very early stages by constant surveillance of abnormal mutaproduction and an increase of Th2 dominance in the immune system would appear to occur (Table 2) .
tions, etc. This was first suggested by Burnett as the immune surveillance theory of cancer, but has been Several authors have clearly associated the dominance of these two different measurable components controversial, mainly because of the relative absence of any increase in solid tumours in patients with a of the immune system with disease, in that the induction of a Th1-or Th2-dominant immune long-term immunosuppressive condition such as AIDS. The only tumours which are associated response can significantly alter the disease phenotype; for instance, HIV and many other chronic with AIDS are those which are associated with viruses, and which appear with increasing immune infections are associated with a loss of Th1 responses and increases in Th2 responses, which occurs against deficiency, e.g. EBV-'driven' lymphomas, HHV8-'driven' Kaposi's sarcoma, and HPV-'driven' cervical the background of a collapsing immune system. 6 The bottom line regarding the application of chaos cancer.8
The fact that the immune system is important in theory to immunology, and its use in the treatment of disease, is that if a complex system such as the controlling solid tumours comes from a number of different observations, the first of which was made immune system can be viewed as a self-referential network based around 'strange attractors', disease by Festenstein and colleagues, that HLA expression on tumours is reduced and increasingly so with the states may lead to a collapse of certain components of the immune network. Conversely, moving the progression of metastatic disease.9 Although a significant trend, this is not the case in all tumours or 'attractor' might change the relationship of the immune system to the disease state, whether an any one tumour type. More recent studies have shown that often the specific MHC/HLA allele is invading organism or a tumour. It is highly likely that when diseases such as melanoma and renal downregulated, and that this is the allele which presents the immunodominant component of a cancer respond to a wide variety of agents such as BCG, interferon, interleukin II and cellular vactumour antigen to the immune system.10 However, as our understanding of the immune system slowly cination, that these non-specific stimulants are altering the immune response by acting on a 'strange' increases, it has become apparent that there are many other layers at which the 'escape' can work.11 attractor. This activity is obviously dependent on the other variable states of the immune response, which MHC (HLA molecules in humans) present(s) peptides to the T-cell receptor, an interaction that can would explain why the response rate to these therapies is consistently similar at around 20-30%, a figure lead to either activation or paradoxically to anergy.
The need for at least one other signal or co-stimulus similar to drug response rates in many hundreds of studies in solid tumours such as lung cancer. The explains this marked difference in activity. Such are now recognized to be deficient in costimulatory and/or normal adhesion molecules.12
The immune system is complex, and even these ligands have recently been identified, such as B7.1 and B7.2. In the presence of these signals, recognition two scenarios would be unlikely to evolve fast enough to escape immune control, and thus other and activation of T cells is induced, however in their absence, not only is there no recognition following mechanisms appear to be used by tumour cells to avoid elimination. Many tumours appear to secrete T-cell receptor/HLA peptide interaction, but anergy is induced. This is clearly in the interest of a tumour cytokines and other messages, which may interfere with their recognition by the cell-mediated arm of cell escaping immune surveillance. It is also likely that other ligands are necessary in this interaction, the immune response, especially humoral cytokines such as IL-6 and IL-10 which downregulate cellsuch as the adhesion molecules, and many tumours Cancer and chaos only the tip of the iceberg, but their importance can Living systems are non-linear, with infinite variation be demonstrated in animal tumour model experiexisting within given parameters. Non-linearity is ments in which poorly immunogenic cells can be probably essential for human development, as the rendered more immunogenic by transfecting cytokine number of neural interactions alone greatly exceeds or stimulatory molecule genes that will induce an (by 2 logs) the number of genes encoding the nervous immune response (where the wild-type tumour will system. Like the nervous system, the immune system not), yet the immune response may be sufficiently is not set in stone but learns and imprints its strong to recognize the wild-type tumour. Such environment. If these were linear systems, then strategies, which have been widely published, clones would be the normal state of affairs! Noninclude the expression of HLA on the tumour cell linearity would also appear essential for rapid adaptaand its use as a vaccine to enhance the presentation tion in other organ systems, such as the cardiovasor tumour antigens, as well as the expression by cular system. Although the heart was initially thought genetic transfer, the addition of co-stimulatory signals to be absolutely regular, speeding up or slowing such as B7-1, and cytokines, e.g. interleukin 2 and gradually depending on oxygen command, it is now c interferon. However, in some animal models, the recognized that the only time the heart beats with cytokines which render tumour cells immunogenic absolute regularity is just before death. At such a are not confined to those associated with Th1, as time, it has lost the variability to respond. An analogy IL-4 and IL-10 can also induce anti-tumour responses is the use of unstable aerodynamics in the new to the wild-type tumour cell.13 generation of fighter aircraft, where unless their These experiments all provide evidence that poorly instability is continually controlled by computer the immunogenic cells can be recognized by the immune aircraft crashes; the advantage however is that such system when their antigens are presented by a more unstable aircraft are much more manoeuverable than effective antigen-presenting cell. This has been taken stable aircraft, whose predictable dynamics also further by the use of 'professional' antigen-presenting make them much easier targets for missiles. cells (APC) such as dendritic cells (DC) to induce strong anti-tumour immune responses against tumour-cell antigens.14 In early experiments, tumour cells were used as a vaccine themselves without
Cancer and heterogeneity-chaos?
really knowing the identity of any specific antigens. A very large effort is now underway identifying Biological systems are essentially non-linear, and with much of the 'phenotype' dependent on the libraries of tumour-cell antigens by CTLs, and more recently by serological analysis. This has led to the environment or other factors, it is becoming increasingly clear that not everything can be predicted from identification of a whole family of new antigens, such as MAGE and MART, which were both origina genome sequence. Genes do not have enough power to encode everything, and much is left to ally identified from cytotoxic T-cell lymphocytes from melanoma patients. Good responses against controlled random integration of cells and systems. For example, there is no need to encode the fingerthese antigens are in some cases associated with regression.15 There is therefore a considerable body print pattern in the gene, as long as the skin is rough for gripping (identical twins do not necessarily have of evidence that the immune system can control 'non-immunogenic' tumours, at least in laboratory identical fingerprints) and the same goes for small blood vessels and pulmonary airways. Such architecanimals. However, in the human clinical setting, it has been observed for a long time that a variety of ture is built at the local level by the interaction of activating and inhibitory growth factors. As long as immune stimulations, particularly with whole-cell vaccines with adjuvants such as BCG, can be helpful, the tissue is built within the prescribed space and function there is no need to detail all the interactions. as described by Morton and his colleagues for melanoma, who not only claim a 2-3 fold increase Such replicative similarity is hence fractal, and the fractal nature of the trached bronchial tree of blood in survival but also an objective effect on established melanoma disease. 16 Similar observations have been vessel supply is obvious (Figure 3) . Having established the necessity of 'chaotic' sysmade with a variety of immunotherapies. More dramatic effects have been seen in solid tumours tems for life, cancer is loss of control of a 'normal' chaotic system resulting in further 'chaos'. Cancer is such as lung cancer, with the induction of antineuronal antibodies following a transfusion with therefore by definition a state of genetic instability, whose effects at the molecular level raise the possibilcross-reactive antibodies, eliminating this established tumour.17 Many other anecdotal reports exist of nonity of specific therapeutic drugs aimed at such areas of instability, as investigated by Vogelstein's group.20 specific immune stimulation leading to responses in solid tumours such as ovarian cancer. 18, 19 This is the crucial question: can unstable pathways able of controlling cancer, as it is hard to identify the first person to seriously try this approach as treatment. Eighteenth century French practitioners refer to the concept as both therapeutic and preventative, using other people's tumours, and it would not be surprising if it was entertained by other civilizations.
The first scientific application of this approach was that of William Coley, a New York surgeon at the turn of the century who besides pioneering immunotherapy was also the first surgeon in New York to obtain a 'radiotherapy machine'. Following culture to mimic this process. Unfortunately, antibiotics were not yet invented and he merely substior aberrant gene expression (or loss of chromosomes tuted death by cancer for death by iatrogenic and gene expression) be targeted to produce new septicaemia. He therefore moved on to bacterial therapies? One initial reaction is that targeting a cell-wall preparations with which he was to work specific apoptotic pathway or similar predicted and improve on for the next 20 years or so. Initially Achilles' heel will only lead to the evolution of the vilified by his peers, who failed to reproduce his instability in many cases, using alternative pathways work with half-hearted attempts, Coley died having as escape routes, and this is the fundamental reason received widespread approbation, including from the why so many standard therapies are limited by low Royal College of Surgeons.22 Unfortunately his work response routes and high relapse rates. The essence did not survive the impact of new radio and chemoof this article is that such instability can be used to therapy developments. Nevertheless, his experience alter the ambit (or orbit) of the tumour, allowing developed the fundamentals, which are as approinherent more complex biological systems to contain priate today with regards to the development of its growth. What is the precedent?
'immunotherapy' such as cancer vaccines and geneIn 1985, NASA launched a satellite, hoping to therapy-based strategies. Briefly, he showed that the intercept the comet Gicobini/Ziner. The satellite, original preparation was crucial (quality control), as known as the 3rd Interplanatory Communication was the dose and administration schedule, as he Explorer (IFEE/ICE/3), was equipped with small discovered that the toxins had to be given repeatedly rockets from which hydrazine fuel was released in for at least 6 months to contain residual disease. It order to make the necessary corrections to place it is likely that most of his colleagues, who rapidly in the correct orbit. Unfortunately, nearly all the fuel disbanded this approach, used substandard schedules was used up in the initial launch procedure, renderthat were unlikely to be effective. ing it unable to propel itself into the appropriate How did Coley's toxins induce such marked orbit to intercept the comet. Undeterred, groups of responses (and very long-term survivors) in patients non-linear mathematicians calculated that the satelwith such lethal conditions as head and neck cancers, lite could be nudged using a small hydrazine burn sarcomas and metastatic melanoma? Modern-day into an unstable orbit from where it could be assessment of Coley's toxins show that they induce a 'nudged' again into another unstable orbit. Repeated marked cytokine release, involving mainly aTNF and five times, this allowed the successful interception cIFN. However, neither of these cytokines given alone with the comet. Similar procedures enabling intercepis likely to induce tumour regression in the human tion millions of miles away have subsequently been situation, in stark contrast to the case of TNF in mice. used with the Vega, Giotti and Galileo satellites, the Most immunotherapy approaches other than Coley's last of which successfully explored Jupiter. 21 toxins tried this century are either passive such as Understanding the chaotic or unstable mathematics monoclonal antibodies, or active, in that they require of cancer and its interplay with the immune system a responding immune system in order to achieve their may enable similar strategies to be employed in the goal, such as vaccines. It is the latter that is more likely treatment of cancer.
to lead to an understanding of how the 'whole' immune response acts against cancer cells.
Cancer and the immune system Vaccines
There would appear to be an almost innate belief The most basic approach to cancer vaccines is to use autologous tumour cells as the vaccine preparathat stimulating the immune system should be cap-tion, and if they are not available, allogeneic tumour all non-specific such as BCG, interferon and interleukin-2. cells. Several waves of interest have occurred in this approach over the last 90 years, the most recent BCG (the tuberculosis vaccine) was used as a treatment in its own right for a variety of conditions, revival is in the guise of gene therapy (GT), where autologous cells are transfected with cytokine genes especially melanoma. The most dramatic results were obtained when the inoculum was given directly into such as interleukin-2 and given as a vaccine. The unfortunate transfer of allogeneic cancer cells, which the lesions. Superficial lesions would necrose and sometimes disappear completely. Unfortunately, simalthough given as a vaccine, occasionally grew in the host, thus giving the host a second malignancy, ilar lesions not injected would not respond, indicating a local response not inducing memory to any marred early studies. The use of radiotherapy to sterilize allogeneic cells has fortunately eliminated shared antigen. Although melanoma is notorious for responding differentially, the lack of such bystander this problem.
Nearly all early gene therapy approaches to treat responses strongly suggests that systemic immunity was not being primed in an antigen-specific manner. cancer were in fact just 'hi-tech' cancer vaccines. Most of these schedules involved the genetic transfer Nevertheless, BCG was able to induce considerable improvement in a number of patients, which and expression of genes encoding cytokines or co-stimulatory molecules into tumour cells to make although individually impressive, were never enough when examined in a randomized trial setting. them more immunogeneic. The even more direct use of gene therapy to kill cancer cells, using
Moreover, BCG has established itself as a highly successful therapy for bladder cancer when given retroviruses to target cancer cells and insert an enzyme which converts a benign prodrug into an intravesically. Its role in vaccine studies is now that of an adjuvant having been used with the GM2 active toxin, e.g. phosphorylating Ganciclovir, appears to induce a significant bystander effect which vaccine developed at the Sloan Kettering by Phillip Livingston and colleagues as well as the allogeneic is immunologically mediated.23 Nevertheless, the similitude between the approaches appears to have cell-line vaccine of Morton and colleagues at the John Wayne Cancer Centre.25,26 escaped the major cancer funding agents (at least in the UK) who were busily closing down their
Interferon was identified as an antiviral agent in the 1950s. There are three main types: alpha, beta Immunology departments with one hand, whilst trying to recruit molecular biologists to develop GT and gamma. Only the first is relevant to cancer therapy. Initial studies used very high doses and on the other. Needless to say this was an impressively expensive exercise in proving that the one thing we resulted in considerable toxicity. The treatment was given intravenously and resulted in some improveneed to understand before engaging in high-tech GT is the immune system, which even if it is not being ments to a number of cancers. However, the high doses involved were very impractical in the absence recruited against the cancer will almost certainly 'take out' the virus vector, particularly if it is of a reliable response. Lower doses were then tried in both treatments, as well as in an adjuvant setting, adenovirus-based.
The history of the development of cancer vaccines for a number of different tumours. The first tumour to show a marked response was the relatively rare is too large to repeat here, but suffice to say that it is replete with impressive anecdotes and unimpresshairy-cell leukaemia, which appeared to differentiate in the presence of interferon and become more ive larger trials, especially if randomized. However, like Coley's toxins, attention to detail distinguishes susceptible to chemotherapy. Used as an adjuvant, it has been shown to increase survival in multiple those with better apparent successes than those with no significant responses. The cell line(s) used, the myeloma. Its role in melanoma remains unproven, in spite of optimistic early studies. Interferon also number of cells used and the administration schedule, especially the frequency, are again very importhas activity in renal-cell cancer, with an activity of between 10 and 20%, being more effective in ant criteria in determining response, and especially the adjuvants used, as they are closely linked with patients who have undergone a nephrectomy first. Initial trials claiming effectiveness in colorectal non-specific immune stimulation (for review see reference 24) .
cancer when added to 5-fluorouracil in an adjuvant setting have not been reproduced. Interleukin-2 had a very similar start to interferon,
Non-specific immunotherapy
with claims that it was very effective when given at high doses particularly with ex vivo expanded Cells have been used on the presumption that they would present tumour antigens to the immune system lymphokine activated killer cells (LAK). Although the treatment was toxic and associated with deaths, even though there was very little concept of what tumour antigens were. The major immunotherapies some patients with melanoma, renal-cell cancer or lymphoma went on to have prolonged remissions. A that have made an impact to date (albeit limited
did not alter dramatically when the ex vivo
The search for tumour-specific antigens has intensified with the advent of new technologies. expansion was omitted, and when lower doses of IL-2 were tried. II-2 is now licensed for renal-cell Boon and colleagues29 have used an elaborate mechanism of using CTLs from patients with cancers cancer, and is being used as a low-dose adjuvant in a small number of studies. As from the beginning which have undergone regression to identify the fragments of tumour expressed as a DNA library. of 1998, it has been licensed for melanoma as well. However, further applications can be anticipated as
The positive fragments are then analysed further with mass spectrometry and peptide identification to its role as an adjuvant or co-stimulatory messenger is appreciated. Direct injection into draining lymph reduce the target to a small peptide sequence, which therefore is dependent on HLA restriction. Members nodes leads to marked softening and occasional regression of breast cancer, and it is surprising that of the melanoma antigen family (MAGE), were the first to be identified and have subsequently been this approach has not been more actively pursued given the interest in vaccines for most solid tumours followed by a number of similar antigens such as PAGE from prostate cancer. including breast cancer. 27 In addition to these specific peptides, it should not be forgotten that many tumour antigens are not Antigen-specific vaccine approaches necessarily peptides, but include gangliosides as previously mentioned as well as lipid-based antigens. Exactly what constitutes a tumour antigen has been the source of many debates over the last two decades
Other antigens are associated with complex structures such as mucin and tumour-specific epitopes or so. The nomenclature includes tumour-associated differentiation antigens (TADA), tumour-specific antisuch as MUC-1 have been described in a number of tumours and are already being targeted for theragens (TSA), as well as tumour-associated antigens (TAA). TADA and TAA antigens are often oncofetal peutic purposes. antigens which are expressed in the fetus and not in normal adult tissue, but can occur in tumours.
Presentation of antigens, camouflage and
Examples include carcinoma embryonic antigen decoys (CEA) and alpha fetoprotein (AFP). Other antigens identified more recently include the MAGE and
The major components of antigen presentation include the antigen-presenting cell with either MHC related families, which are present on tumour cells and are present, but not expressed or presented, in class I or II on its surface, presenting an antigen as a peptide to the T-cell receptor on CD8 and CD4 some normal tissues. Other antigens are apparently tumour-specific such as MART, and oncogene mutacells, respectively ( Figure 4) . A major problem with this model is that it has been described as being tions such as ras 12, which is present in the majority of pancreatic cancer cells. Viral antigens associated able to induce not only antigen-specific proliferation but also actively induce anergy to the same antigen. with tumour cells are also potential TSAs, especially considering the number of human tumours associated
The discovery of co-stimulatory molecules such as B7-1 and B7-2, which present to associated molecwith oncogenic viruses: cervical cancer with papilloma viruses, nasopharyngeal and Burkitt's lymules such as CD28 on the T cell, explained this conundrum, as the absence of the co-stimulatory phoma with Epstein Barr virus, and hepatoma with hepatitis B virus. More recently, human retroviruses signal results in anergy. It is therefore not surprising that defects in this pathway are common amongst have been linked to adult T-cell leukaemialymphoma (HTLV-1) and AIDS, which is associated tumours, which if they do not down-regulate their MHC molecules or alleles, downregulate their with lymphomas and Kaposis's sarcoma (KS), is caused by HIV. However the specific cause of KS costimulatory molecules. This is just the beginning of their ability to effectively evade immune control, appears to be a new herpes virus (HHV-8) which may be activated by HIV. It is unclear whether these and hence strongly supports that, contrary to previous dogma, the immune response probably does play a viral antigens will allow for the development of treatment based on vaccines. Nevertheless, a successmajor role in immune surveillance as postulated by Burnett. Other mechanisms used to evade an immune ful vaccine against HBV already exists and is responsible for a marked decline in the incidence of HBV response include switching on anti-apoptotic pathways by such mechanisms as up-regulation of c-myc infection and hence future hepatomas, and can therefore already claim in some sense to be an and other genes, expressing the fas ligand so that the incoming lymphocytes are apoptosed by a signal effective anti-cancer vaccine.28 There is a tremendous flurry of activity with regards the development of HPV from the tumour, and the secretion of locally-acting immunosuppressive molecules such as the humand EBV vaccines and clinical trials have already autologous because of the need for haplotype restriction. However a number of studies, including those of our own laboratory,32 strongly suggest that allogeneic cells can serve just as well with regards to a source of tumour antigens, as the cells are digested and the antigens presented by the hosts dendritic cells in a haplotype-restricted manner. This is very encouraging for the development of multivalent vaccines, as autologous vaccines are restricted with regards to their practical application, due to the difficulty in obtaining enough tumour and establishing a cell line in many cases. Indeed, only melanoma constitutes a readily accessible supply of cells that can be grown in a cell line in as many as 50% of attempted cases. Even then, the patients are often dead by the time enough cells have been patients with leukaemia who have an allogeneic marrow transplant and develop graft versus host disease have a better survival than those that do not. orally-based cytokines, e.g. IL-10, IL-4. In addition to the foregoing there is also some evidence that the Moreover, a graft versus leukaemia activity can be separated from GVH in these patients. It is possible signalling mechanisms of otherwise normal lymphocytes are inhibited in cancer patients, by a mechanthat allogeneic cells can induce a graft versus tumour response in some cancers.33 ism which is unclear. 30 It is therefore no surprise that the antigen presentaAnother major issue is whether or not the most effective response results from a class-I-induced CTL tion needs to be a top priority for cancer vaccines in order to overcome the generalized lethargy of the response, or whether a class II response is necessary instead, or as well. Thus it is essential to establish immune system and the tumour-specific anergy. This explains why powerful adjuvants are needed and correlates of protection in both animal models and in human disease. Another issue not touched on why the stimulus must be given at regular intervals, in contrast to infectious-disease-based vaccines.
previously here is the role of Natural Killer (NK) cells, which are capable of killing MHC-negative With a growing body of evidence suggesting that an effective anti-tumour response needs to be able cells which have thus evaded MHC restricted killing. NK cells are stimulated by IL-12, which was to enhance the cell-mediated or Th1 cytokine profile, this may explain the relative lack of efficacy of originally known as NK growth factor, and hence it is likely that NK cells may play an important role in earlier studies using either no adjuvants at all or inappropriate ones such as alum. Even BCG, a cell-mediated or Th1-like responses. It is also important to note that the most important anti-tumour popular adjuvant for cell-based vaccines, does not always stimulate the same immune response in response may require an immune component not yet discovered or poorly understood, and that more different populations, which may explain its failure to act as a universal TB vaccine throughout the than one aspect of the immune response is required for an effective response. The complexity of the world. It appears that its response is determined by other factors such as the prior setting of the immune immune response to an aberrant self cell cannot be overstated. The fact that tumours express self antigens response with regards the dominance of a Th1 or Th2 profile. The 'professional' antigen-presenting cell to which the immune system is tolerant shows that they have mastered the art of decoy. However, there would appear to be the dendritic cell, which needs activation and maturation for optimal function. Trials is cause for optimism in the development of tumour vaccines, in that responses to some of these antigens designed to maximize its potential are now underway in the clinic using in vitro expanded dendritic cells seem to be able to distinguish an antigen on a tumour from the same antigen on a normal cell. pulsed with tumour peptides before being used as a vaccine.
It is proposed that the nature of the non-specific immune stimulation, like the importance of starting Whole-cell-based vaccines have tended to be Figure 5 . The strange attractor of Lorenz, who first noticed that 2D reiteration of some equations gave unpredictable results when trying to predict weather patterns during WW II. Although individual pathways are variable, they focus around the double attractor and it is hypothesized here that this may be a suitable model for the immune system, with the two opposite attractor centres representing Th1 and Th2, respectively. If one attractor were influenced by an external force then a shift of Th1 downward would move the whole wing pattern to a different balance with the complexity of the orbits altering accordingly. Removing the external force should lead to resetting of the 'horizontal' attractor. In Th1/Th2 terms, a chronic disease when removed or cured should lead to a return to the normal immune status of a balance of the two immune types. It should be noted that this is a highly allegorical model only and not to be taken literally.
conditions in chaos theory, determines large changes of the tumour, this function (measured in the peripheral blood!) reverts to normal in the majority of in the outcome. That small changes in key cytokines can induce marked clinical changes in clinical cases with the exception of some patients with Duke's C or advanced disease that has split outside conditions has already been demonstrated using inhibitors of TNF-a such as antibodies or thalidomthe colon wall. It is not yet known whether these patients have a higher chance of relapsing in the ide,34 which can lead to marked clinical improvements in severe rheumatoid arthritis, aphthous ulcers, near future. (Heriot et al. submitted) In patients with melanoma in which the Th1 or Behçet's disease and Crohn's disease, to name but a few, in a matter of days.
cell-mediated cytokine production can be restored with vaccination, complete and partial responses of Many cancers, in common with a number of infectious diseases, appear to have lost cell-mediated established disease have been witnessed, as the balance between Th2 and Th1 cytokines is reversed immunity which can only be measured by the induction of IL-2 and cIFN by PMA-stimulated whole in favour of the latter. Survival would also appear to be significantly improved in stage 4 patients with blood. In a study looking at patients with colorectal cancer, we were able to demonstrate a marked malignant melanoma treated with Mycobacterium vaccae (a relative of BCG) which induces a Th1 reduction in cytokines associated with monocyte cell stimulation in patients with all grades of tumour, cytokine response in approximately a third of those treated. A similar benefit has been seen in prostate even early Duke's A and B tumours. Upon removal
